“…Elevated OPN levels have been reported in the lungs of patients with asthma, COPD, or pulmonary fibrosis, or a combination of the above [7e11] and are linked to pathological features of these diseases, including eosinophil and neutrophil infiltration [12,13], goblet cell hyperplasia [14,15], airway hyper-responsiveness [13,14], and fibrosis [11,15,16]. Shan et al have recently demonstrated in mice that chronic exposure to CS induces Opn mRNA expression in lung dendritic cells, which in turn stimulates differentiation of Th17 cells and thus interleukin 17A (IL-17A)-driven inflammation, eventually leading to emphysema [17,18].…”